SEC-sourced researchBeta

ELAN

Elanco Animal Health Inc

US markets

Data passport

CIK: 0001739104
Exchange: NYSE
Business activity: — · SIC 2834
Financial inputs: 6/6
Filing date: Oct 6, 2026
SEC registry record: Operating company

Last updated: Oct 8, 2026, 9:09 AM UTCSEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Chart metric

ELAN · Exact amounts and source periods · USD
Period end	Revenue	Filing date
December 2023	4,417,000,000.0000	Feb 24, 2026
December 2024	4,439,000,000.0000	Feb 24, 2026
December 2025	4,715,000,000.0000	Feb 24, 2026

Annual periods · USD

Period end	Revenue	Net income	Operating cash flow	Total assets	Total liabilities	Filing date
December 2025	4,715,000,000.0000	-232,000,000.0000	560,000,000.0000	13,358,000,000.0000	6,811,000,000.0000	Feb 24, 2026
December 2024	4,439,000,000.0000	338,000,000.0000	541,000,000.0000	12,614,000,000.0000	6,518,000,000.0000	Feb 24, 2026
December 2023	4,417,000,000.0000	-1,231,000,000.0000	271,000,000.0000	—	—	Feb 24, 2026

Financial inputs behind the calculation

Financial inputs	USD	Period end	Filing date	Form
RevenueRevenueFromContractWithCustomerExcludingAssessedTax	$4.72B	December 2025	Feb 24, 2026	10-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax	$4.44B	December 2024	Feb 24, 2026	10-K
Net incomeNetIncomeLoss	-$232M	December 2025	Feb 24, 2026	10-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities	$560M	December 2025	Feb 24, 2026	10-K
Total assetsAssets	$13.36B	December 2025	Feb 24, 2026	10-K
Total liabilitiesLiabilities	$6.81B	December 2025	Feb 24, 2026	10-K

New filings

Explore methodology ↗